DBV Technologies participera au prochain congrès EAACI 2024
May 30, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 30 mai (22h30 CEST) 2024 DBV Technologies participera au prochain congrès EAACI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une...
American Lithium Announces Financial and Operating Highlights for Year and Quarter Ended February 29, 2024
May 30, 2024 16:30 ET
|
American Lithium Corp.
VANCOUVER, British Columbia, May 30, 2024 (GLOBE NEWSWIRE) -- American Lithium Corp. (“American Lithium” or the “Company”) (TSX-V:LI | Nasdaq:AMLI | Frankfurt:5LA1) is pleased to provide financial...
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 30, 2024 16:25 ET
|
Supernus Pharmaceuticals, Inc.
ROCKVILLE, Md., May 30, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
May 30, 2024 16:05 ET
|
Larimar Therapeutics
START is a new milestone-driven program designed to accelerate development of novel therapies intended to address an unmet medical need for rare diseasesNomlabofusp was selected based on potential for...
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
May 30, 2024 16:05 ET
|
NextCure
Of the evaluable ICI-naïve MSS/MSI-L CRC patients without liver metastasis, there were 2 confirmed ongoing PRs and a disease control rate of 51%Of the 7 evaluable ovarian cancer patients, there were 3...
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
May 30, 2024 16:01 ET
|
Caribou Biosciences, Inc.
BERKELEY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’s...
Immunocore to present at the Jefferies Global Healthcare Conference
May 30, 2024 16:00 ET
|
Immunocore Holdings plc
Immunocore to present at the Jefferies Global Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 30 May 2024) Immunocore Holdings plc (Nasdaq: IMCR)...
6 Tips to Prevent Pickleball Injuries to Your Feet & Ankles
May 30, 2024 15:31 ET
|
American Orthopaedic Foot & Ankle Society (AOFAS)
Rosemont, Ill., May 30, 2024 (GLOBE NEWSWIRE) -- As the weather warms up, more people are looking for ways to get outside and enjoy sports like pickleball. Pickleball has grown in popularity, but...
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société
May 30, 2024 12:15 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics fait le point sur ses avancées et sur la stratégie de croissance de la Société Trois accords pharmaceutiques signés au cours des trois derniers mois : Un nouveau partenariat...
OSE Immunotherapeutics Provides Business and Corporate Update
May 30, 2024 12:15 ET
|
OSE Immunotherapeutics
OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months: New strategic partnership with AbbVie for OSE-230, a novel...